AGIO
Price
$40.00
Change
+$0.35 (+0.88%)
Updated
Jul 25 closing price
Capitalization
2.32B
5 days until earnings call
BLTE
Price
$62.24
Change
+$0.39 (+0.63%)
Updated
Jul 25 closing price
Capitalization
2.03B
11 days until earnings call
Interact to see
Advertisement

AGIO vs BLTE

Header iconAGIO vs BLTE Comparison
Open Charts AGIO vs BLTEBanner chart's image
Agios Pharmaceuticals
Price$40.00
Change+$0.35 (+0.88%)
Volume$529.14K
Capitalization2.32B
Belite Bio
Price$62.24
Change+$0.39 (+0.63%)
Volume$20.6K
Capitalization2.03B
AGIO vs BLTE Comparison Chart in %
Loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGIO vs. BLTE commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a Hold and BLTE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (AGIO: $40.00 vs. BLTE: $62.24)
Brand notoriety: AGIO and BLTE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 83% vs. BLTE: 40%
Market capitalization -- AGIO: $2.32B vs. BLTE: $2.03B
AGIO [@Biotechnology] is valued at $2.32B. BLTE’s [@Biotechnology] market capitalization is $2.03B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 1 FA rating(s) are green whileBLTE’s FA Score has 0 green FA rating(s).

  • AGIO’s FA Score: 1 green, 4 red.
  • BLTE’s FA Score: 0 green, 5 red.
According to our system of comparison, AGIO is a better buy in the long-term than BLTE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 3 TA indicator(s) are bullish while BLTE’s TA Score has 4 bullish TA indicator(s).

  • AGIO’s TA Score: 3 bullish, 5 bearish.
  • BLTE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both AGIO and BLTE are a bad buy in the short-term.

Price Growth

AGIO (@Biotechnology) experienced а 0.00% price change this week, while BLTE (@Biotechnology) price change was +2.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

AGIO is expected to report earnings on Oct 30, 2025.

BLTE is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGIO($2.32B) has a higher market cap than BLTE($2.03B). AGIO YTD gains are higher at: 21.729 vs. BLTE (-1.363). BLTE has higher annual earnings (EBITDA): -43.31M vs. AGIO (-434.71M). AGIO has higher revenues than BLTE: AGIO (37M) vs BLTE (0).
AGIOBLTEAGIO / BLTE
Capitalization2.32B2.03B114%
EBITDA-434.71M-43.31M1,004%
Gain YTD21.729-1.363-1,594%
P/E Ratio3.47N/A-
Revenue37M0-
Total Cash893MN/A-
Total Debt52.9MN/A-
FUNDAMENTALS RATINGS
AGIO: Fundamental Ratings
AGIO
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
17
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
68
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGIOBLTE
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 10 days ago
77%
Bullish Trend 13 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
76%
Bearish Trend 9 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PKSFX57.10N/A
N/A
Virtus KAR Small-Cap Core I
RGSAX35.33N/A
N/A
Virtus KAR Global Small-Cap A
JGETX13.03N/A
N/A
JHancock Global Equity R4
KCGSX22.77N/A
N/A
Knights of Columbus Large Cap Growth S
OGFAX95.57N/A
N/A
JPMorgan Equity Index R6

BLTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLTE has been loosely correlated with RAIN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLTE jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
+0.63%
RAIN - BLTE
48%
Loosely correlated
+0.44%
ACOG - BLTE
24%
Poorly correlated
+0.10%
LENZ - BLTE
23%
Poorly correlated
-5.33%
NAMS - BLTE
23%
Poorly correlated
+0.90%
AGIO - BLTE
22%
Poorly correlated
+0.88%
More